Acarix AB Stock Deutsche Boerse AG
Equities
7AC
SE0009268717
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 EUR | +9.02% | +14.17% | +90.79% |
May. 27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
May. 14 | Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024 |
Sales 2024 * | 54.3M 5.16M 4.76M | Sales 2025 * | 177M 16.78M 15.46M | Capitalization | 301M 28.62M 26.38M |
---|---|---|---|---|---|
Net income 2024 * | -54M -5.13M -4.73M | Net income 2025 * | 2M 190K 175K | EV / Sales 2024 * | 5.55 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.96% |
Latest transcript on Acarix AB
1 day | +9.02% | ||
1 week | +14.17% | ||
1 month | +70.59% | ||
3 months | +26.64% | ||
6 months | +90.79% | ||
Current year | +90.79% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Director/Board Member | 59 | 19-12-31 |
Date | Price | Change |
---|---|---|
24-05-31 | 0.029 | +9.02% |
24-05-30 | 0.0266 | +0.38% |
24-05-29 | 0.0265 | -0.38% |
24-05-28 | 0.0266 | +34.34% |
24-05-27 | 0.0198 | -22.05% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 03:11 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
-26.08% | 846M | |
+3.53% | 811M | |
-24.63% | 631M |
- Stock Market
- Equities
- ACARIX Stock
- 7AC Stock